AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired

Michael T. Rogan, Ursula V. Stäubli, Joseph Ledoux

Research output: Contribution to journalArticle

Abstract

Rats treated with the AMPA receptor-facilitating drug 1-(quinoxolin-6- ylcarbonyl)piperidine (BDP-12) during training acquired fear conditioning to a tone faster than vehicle-treated controls. The effect on acquisition was dependent on the dose given. BDP-12-treated rats and vehicle-treated controls reached the same level of conditioned fear and extinguished at the same rate. The dissociation of learning rate from these other normally covariant measures suggests that the drug had a specific and isolated effect on acquisition. Controls for drug effects on stimulus sensitivity, locomotor activity, generalized fearfulness, and other performance factors support this interpretation. The known action of BDP-12 on receptor dynamics suggests that its effect on acquisition may be attributed to specific modulation of an AMPA and NMDA receptor-dependent plasticity mechanism. The finding that the drug accelerates acquisition but does not affect the level of conditioned fear acquired parallels the effect of the drug on long-term potentiation (LTP) (increasing the rate but not the ceiling of potentiation) and suggests that common mechanisms may undelie fear conditioning and LTP.

Original languageEnglish (US)
Pages (from-to)5928-5935
Number of pages8
JournalJournal of Neuroscience
Volume17
Issue number15
StatePublished - Aug 1 1997

Fingerprint

AMPA Receptors
Fear
Learning
Long-Term Potentiation
Pharmaceutical Preparations
Drug and Narcotic Control
Locomotion
N-Methyl-D-Aspartate Receptors
1-(quinoxalin-6-ylcarbonyl)piperidine
Conditioning (Psychology)

Keywords

  • AMPA receptors
  • Amygdala
  • Fear
  • Glutamate
  • Learning
  • NMDA receptors

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired. / Rogan, Michael T.; Stäubli, Ursula V.; Ledoux, Joseph.

In: Journal of Neuroscience, Vol. 17, No. 15, 01.08.1997, p. 5928-5935.

Research output: Contribution to journalArticle

@article{ba1b0de5bbb54334909471f3fd09d329,
title = "AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired",
abstract = "Rats treated with the AMPA receptor-facilitating drug 1-(quinoxolin-6- ylcarbonyl)piperidine (BDP-12) during training acquired fear conditioning to a tone faster than vehicle-treated controls. The effect on acquisition was dependent on the dose given. BDP-12-treated rats and vehicle-treated controls reached the same level of conditioned fear and extinguished at the same rate. The dissociation of learning rate from these other normally covariant measures suggests that the drug had a specific and isolated effect on acquisition. Controls for drug effects on stimulus sensitivity, locomotor activity, generalized fearfulness, and other performance factors support this interpretation. The known action of BDP-12 on receptor dynamics suggests that its effect on acquisition may be attributed to specific modulation of an AMPA and NMDA receptor-dependent plasticity mechanism. The finding that the drug accelerates acquisition but does not affect the level of conditioned fear acquired parallels the effect of the drug on long-term potentiation (LTP) (increasing the rate but not the ceiling of potentiation) and suggests that common mechanisms may undelie fear conditioning and LTP.",
keywords = "AMPA receptors, Amygdala, Fear, Glutamate, Learning, NMDA receptors",
author = "Rogan, {Michael T.} and St{\"a}ubli, {Ursula V.} and Joseph Ledoux",
year = "1997",
month = "8",
day = "1",
language = "English (US)",
volume = "17",
pages = "5928--5935",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "15",

}

TY - JOUR

T1 - AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired

AU - Rogan, Michael T.

AU - Stäubli, Ursula V.

AU - Ledoux, Joseph

PY - 1997/8/1

Y1 - 1997/8/1

N2 - Rats treated with the AMPA receptor-facilitating drug 1-(quinoxolin-6- ylcarbonyl)piperidine (BDP-12) during training acquired fear conditioning to a tone faster than vehicle-treated controls. The effect on acquisition was dependent on the dose given. BDP-12-treated rats and vehicle-treated controls reached the same level of conditioned fear and extinguished at the same rate. The dissociation of learning rate from these other normally covariant measures suggests that the drug had a specific and isolated effect on acquisition. Controls for drug effects on stimulus sensitivity, locomotor activity, generalized fearfulness, and other performance factors support this interpretation. The known action of BDP-12 on receptor dynamics suggests that its effect on acquisition may be attributed to specific modulation of an AMPA and NMDA receptor-dependent plasticity mechanism. The finding that the drug accelerates acquisition but does not affect the level of conditioned fear acquired parallels the effect of the drug on long-term potentiation (LTP) (increasing the rate but not the ceiling of potentiation) and suggests that common mechanisms may undelie fear conditioning and LTP.

AB - Rats treated with the AMPA receptor-facilitating drug 1-(quinoxolin-6- ylcarbonyl)piperidine (BDP-12) during training acquired fear conditioning to a tone faster than vehicle-treated controls. The effect on acquisition was dependent on the dose given. BDP-12-treated rats and vehicle-treated controls reached the same level of conditioned fear and extinguished at the same rate. The dissociation of learning rate from these other normally covariant measures suggests that the drug had a specific and isolated effect on acquisition. Controls for drug effects on stimulus sensitivity, locomotor activity, generalized fearfulness, and other performance factors support this interpretation. The known action of BDP-12 on receptor dynamics suggests that its effect on acquisition may be attributed to specific modulation of an AMPA and NMDA receptor-dependent plasticity mechanism. The finding that the drug accelerates acquisition but does not affect the level of conditioned fear acquired parallels the effect of the drug on long-term potentiation (LTP) (increasing the rate but not the ceiling of potentiation) and suggests that common mechanisms may undelie fear conditioning and LTP.

KW - AMPA receptors

KW - Amygdala

KW - Fear

KW - Glutamate

KW - Learning

KW - NMDA receptors

UR - http://www.scopus.com/inward/record.url?scp=0342601397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342601397&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 5928

EP - 5935

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 15

ER -